Executives from biotech and pharmaceutical companies, along with investment firms from North America, Europe, and Asia, will convene for 3rd annual BIO Convention in China, where they will meet and explore business opportunities with China’s emerging biotech sector. Panel sessions will highlight latest issues and trends, and will include science-focused topics such as vaccine development, China’s unmet medical needs, and research and development of orphan drugs to treat rare diseases in China. ...